Back to Search
Start Over
IMPACT OF VITREORETINAL INTERFACE ARCHITECTURE ON SUCCESSFUL VITREOMACULAR TRACTION RESOLUTION IN EYES SCHEDULED FOR INTRAVITREAL OCRIPLASMIN THERAPY
- Source :
- Retina. 37:1252-1260
- Publication Year :
- 2017
- Publisher :
- Ovid Technologies (Wolters Kluwer Health), 2017.
-
Abstract
- PURPOSE To evaluate the impact of the vitreoretinal interface architecture, in specific the angle between the posterior vitreous cortex and the internal limiting membrane, on vitreomacular traction (VMT) resolution in eyes treated with intravitreally injected ocriplasmin (Jetrea). METHODS Retrospective, multicenter cohort study and exploratory data analysis. Spectral domain optical coherence tomography assessments were performed before scheduled ocriplasmin injections. General (age and sex) as well as ocular variables (lens status, presence of epiretinal membrane formations, horizontal diameter of VMT, central retinal thickness, and in particular various prespecified angles between the posterior vitreous cortex and internal limiting membrane) were analyzed to evaluate their impact on successful VMT resolution. RESULTS Fifty-nine eyes of 59 patients were included. Univariate analysis of age (odds ratio [OR]: 0.881; 95% CI: [0.812-0.955]; P = 0.0022) and lens status (OR: 11.03; 95% CI: [2.23-54.57]; P = 0.0033) had a significant impact on successful VMT resolution, whereas sex (OR: 0.668; 95% CI: [0.126-2.065]; P = 0.4906), epiretinal membrane formation (OR: 0.581; 95% CI: [0.168-2.006]; P = 0.3903), horizontal diameter of VMT (OR: 0.99930; 95% CI: [0.99825-1.00035]; P = 0.1886), and central retinal thickness (OR: 0.9985; 95% CI: [0.9934-1.00436]; P = 0.56) failed. The angle at 500 μm apart from the fovea centralis, irrespective if measured nasally (OR: 1.135; 95% CI: [1.013-1.272]; P = 0.0289) or temporally (OR: 1.099; 95% CI: [1.001-1.208]; P = 0.0485), showed a significant correlation with VMT resolution. CONCLUSION The angle between the posterior vitreous cortex and the internal limiting membrane 500 μm apart from the fovea centralis correlates with VMT resolution and may be a clinically useful marker for selection of patients to be treated with ocriplasmin. This observation needs to be proven in a prospective confirmatory investigation.
- Subjects :
- Male
medicine.medical_specialty
Time Factors
Visual acuity
Visual Acuity
Vitreomacular traction
Retina
03 medical and health sciences
chemistry.chemical_compound
0302 clinical medicine
Retinal Diseases
Ophthalmology
medicine
Humans
Fibrinolysin
030212 general & internal medicine
Aged
Retrospective Studies
Univariate analysis
business.industry
Ocriplasmin
Fovea centralis
Retinal
General Medicine
medicine.disease
Peptide Fragments
Vitreous Body
Treatment Outcome
medicine.anatomical_structure
Vitreous membrane
chemistry
Intravitreal Injections
030221 ophthalmology & optometry
Female
Epiretinal membrane
medicine.symptom
business
Tomography, Optical Coherence
Follow-Up Studies
Subjects
Details
- ISSN :
- 0275004X
- Volume :
- 37
- Database :
- OpenAIRE
- Journal :
- Retina
- Accession number :
- edsair.doi.dedup.....7b1d6d6dacfef2fb92e5fe0d037b26ab
- Full Text :
- https://doi.org/10.1097/iae.0000000000001371